{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:11:45Z","timestamp":1778638305278,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004851","name":"Medical University - Pleven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["\\u041A\\u041F\\u221206-\\u041D41\/4"],"award-info":[{"award-number":["\\u041A\\u041F\\u221206-\\u041D41\/4"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["06-\\u041D31\/16"],"award-info":[{"award-number":["06-\\u041D31\/16"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["41\/4"],"award-info":[{"award-number":["41\/4"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["31\/16"],"award-info":[{"award-number":["31\/16"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology &amp; Behavior"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.physbeh.2021.113525","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T10:55:34Z","timestamp":1625568934000},"page":"113525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Chronic agomelatine treatment alleviates icvA\u03b2-induced anxiety and depressive-like behavior through affecting A\u03b2 metabolism in the hippocampus in a rat model of Alzheimer's disease"],"prefix":"10.1016","volume":"239","author":[{"given":"Kalina","family":"Ilieva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Atanasova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrinka","family":"Atanasova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Kortenska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Tchekalarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2021.113525_bib0001","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000110738","article-title":"Neuropsychiatric syndromes in dementia. results from the european alzheimer disease. consortium: part i","volume":"24","author":"Aalten","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.physbeh.2021.113525_bib0002","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.brainresbull.2016.02.005","article-title":"Neuroprotective effects of metformin against a\u03b2-mediated inhibition of long-term potentiation in rats fed a high-fat diet","volume":"121","author":"Asadbegi","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.physbeh.2021.113525_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17070","article-title":"Study of the use of antidepressants for depression in dementia: the hta-sadd trial\u2014a multicentre, randomised, double-blind, placebocontrolled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine","volume":"17","author":"Banerjee","year":"2013","journal-title":"Heal. Technol. Assess."},{"key":"10.1016\/j.physbeh.2021.113525_bib0004","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.physbeh.2021.113525_bib0005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.maturitas.2014.05.009","article-title":"Depression and dementia: cause, consequence or coincidence?","volume":"79","author":"Bennett","year":"2014","journal-title":"Maturit."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113525_bib0006","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1139\/jpn.0414","article-title":"Antidepressant-like activity of s 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors","volume":"29","author":"Bourin","year":"2004","journal-title":"J. Psychiatry. Neurosci. [Internet]."},{"key":"10.1016\/j.physbeh.2021.113525_bib0007","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3389\/fphar.2019.00644","article-title":"Astrocyte function is affected by aging and not alzheimer's disease: a preliminary investigation in hippocampi of 3xtg-ad mice","volume":"10","author":"Bronzuoli","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.physbeh.2021.113525_bib0008","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fphar.2019.01067","article-title":"Pharmacological treatment of depression in alzheimer's disease: a challenging task","volume":"10","author":"Cassano","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113525_bib0009","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.expneurol.2007.10.009","article-title":"Abeta(1-42) injection causes memory impairment, lowered cortical and serum bdnf levels, and decreased hippocampal 5-ht(2a) levels","volume":"210","author":"Christensen","year":"2008","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113525_bib0010","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1006\/bbrc.2000.3051","article-title":"Oligomerization and toxicity of beta-amyloid-42 implicated in alzheimer's disease","volume":"273","author":"El-Agnaf","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.physbeh.2021.113525_bib0011","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3416028","article-title":"Oxidative stress in aging brain: nutritional and pharmacological interventions for neurodegenerative disorders","volume":"2018","author":"Giudetti","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.physbeh.2021.113525_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2018.11.007","article-title":"Antidepressant agomelatine attenuates behavioral deficits and concomitant pathology observed in streptozotocin-induced model of alzheimer's disease in male rats","volume":"107","author":"Ilieva","year":"2019","journal-title":"Horm. Behav."},{"key":"10.1016\/j.physbeh.2021.113525_bib0013","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.psychres.2017.10.008","article-title":"Glucocorticoid may influence amyloid \u03b2 metabolism in patients with depression","volume":"259","author":"Ishijima","year":"2018","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.physbeh.2021.113525_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yhbeh.2013.04.009","article-title":"A novel melatonin agonist neu-p11 facilitates memory performance and improves cognitive impairment in a rat model of alzheimer\u02bc disease","volume":"64","author":"He","year":"2013","journal-title":"Horm. Behav."},{"key":"10.1016\/j.physbeh.2021.113525_bib0015","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1097\/00029330-200811020-00019","article-title":"Altered angiotensin- converting enzyme and its effects on the brain in a rat model of alzheimer disease","volume":"121","author":"Hou","year":"2008","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.physbeh.2021.113525_bib0016","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1099-1166(199802)13:2<100::AID-GPS738>3.0.CO;2-J","article-title":"A double-blind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia","volume":"13","author":"Katona","year":"1998","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.physbeh.2021.113525_bib0017","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/14656566.2018.1471136","article-title":"Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorder","volume":"19","author":"Lozupone","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113525_bib0018","doi-asserted-by":"crossref","first-page":"pyw003","DOI":"10.1093\/ijnp\/pyw003","article-title":"Agomelatine increases bdnf serum levels in depressed patients in correlation with the improvement of depressive symptoms","volume":"19","author":"Martinotti","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2021.113525_bib0019","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jagp.2015.12.003","article-title":"Amyloid hypothesis: is there a role for antiamyloid treatment in late-life depression?","volume":"24","author":"Mahgoub","year":"2016","journal-title":"Am. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.physbeh.2021.113525_bib0020","first-page":"1094","article-title":"Imaging of tau pathology in a tauopathy mouse model and in alzheimer patients compared to normal controls","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neur."},{"key":"10.1016\/j.physbeh.2021.113525_bib0021","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/JMN:17:2:101","article-title":"Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage alzheimer's disease","volume":"17","author":"Morris","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.physbeh.2021.113525_bib0022","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0447.1992.tb03242.x","article-title":"A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia","volume":"86","author":"Nyth","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.physbeh.2021.113525_bib0023","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pnpbp.2012.12.016","article-title":"Heterogeneity of elderly depression: increased risk of alzheimer\u2019s disease and abeta protein metabolism","volume":"43","author":"Namekawa","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113525_bib0024","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.physbeh.2021.113525_bib0025","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.npp.1300091","article-title":"Effect of agomelatine in the chronicmild stress model of depression in the rat","volume":"28","author":"Papp","year":"2003","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2021.113525_bib0026","series-title":"The Rat Brain in Stereotaxic Coordinates in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.physbeh.2021.113525_bib0028","unstructured":"Prince, M., Comas-Herrera, A., Knapp, M., Guerchet, M., Karagiannidou, M., World alzheimer report 2016. improving healthcare for people living with dementia. coverage, quality and costs now and in the future. Alzheimer\u02bcs Dis. Int. 1\u2013140 2016 https:\/\/www.alz.co.uk\/research\/world-report-2016."},{"key":"10.1016\/j.physbeh.2021.113525_bib0029","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.63.2.161","article-title":"Increased hippocampal plaques and tangles in patients with alzheimer disease with a lifetimehistory of major depression","volume":"63","author":"Rapp","year":"2006","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.physbeh.2021.113525_bib0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3233\/JAD-2009-1013","article-title":"Oxidative stress in diabetes and alzheimer's disease","volume":"16","author":"Reddy","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2021.113525_bib0031","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2021.113525_bib0032","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41398-017-0076-4","article-title":"Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of alzheimer's disease by exerting anti-inflammatory and neuroprotective effects","volume":"8","author":"Scuderi","year":"2018","journal-title":"Transl. Psychiatr."},{"key":"10.1016\/j.physbeh.2021.113525_bib0034","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.celrep.2017.05.034","article-title":"The alzheimer's disease \u03b3-secretase generates higher 42:40 ratios for \u03b2-amyloid than for p3 peptides","volume":"19","author":"Siegel","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.physbeh.2021.113525_bib0035","first-page":"1","article-title":"Comparative analysis of intrahippocampal amyloid beta (1-42) and intracerbroventricular streptozotocin models of alzheimer\u2019s disease: possible behavioral, biochemical, mitochondrial, cellu lar and histopathological evidences","volume":"6","author":"Singh","year":"2016","journal-title":"J. Alzheimer\u2019s Dis. Park."},{"issue":"9","key":"10.1016\/j.physbeh.2021.113525_bib0036","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/01616412.2016.1209337","article-title":"Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior","volume":"38","author":"Sharma","year":"2016","journal-title":"Neurol. Res."},{"key":"10.1016\/j.physbeh.2021.113525_bib0037","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.physbeh.2018.02.033","article-title":"Agomelatine's effect on circadian locomotor rhythm alteration and depressive-like behavior in 6-ohda lesioned rats","volume":"188","author":"Souza","year":"2018","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2021.113525_bib0038","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1037\/0033-295X.99.2.195","article-title":"Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans","volume":"99","author":"Squire","year":"1992","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.physbeh.2021.113525_bib0039","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2015.12.043","article-title":"Consequences of long-term treatment with agomelatine on depressive-like behavior and neurobiological abnormalities in pinealectomized rats","volume":"302","author":"Tchekalarova","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2021.113525_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2017.04.017","article-title":"Agomelatine protects against neuronal damage without preventing epileptogenesis in the kainate model of temporal lobe epilepsy","volume":"104","author":"Tchekalarova","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.physbeh.2021.113525_bib0041","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2018.04.005","article-title":"Chronic agomelatine treatment prevents comorbid depression in the post-status epilepticus model of acquired epilepsy through suppression of inflammatory signaling","volume":"115","author":"Tchekalarova","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113525_bib0042","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00213-019-05385-y","article-title":"Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases mt1 receptor as well as bdnf expression in the hippocampus during the subjective light phase of rats exposed to chronic constant light","volume":"237","author":"Tchekalarova","year":"2020","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.physbeh.2021.113525_bib0043","series-title":"Elsevier's Integrated Pathology","first-page":"337","article-title":"14 - Nervous system","author":"King","year":"2007"},{"key":"10.1016\/j.physbeh.2021.113525_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mppsy.2007.11.009","article-title":"The molecular pathology of alzheimer\u2019s disease","volume":"7","author":"Yates","year":"2008","journal-title":"Psychiatr"},{"issue":"3\u20134","key":"10.1016\/j.physbeh.2021.113525_bib0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0928-4257(98)80035-1","article-title":"The role of A beta 42 in alzheimer's disease","volume":"92","author":"Younkin","year":"1998","journal-title":"J. Physiol. Paris."}],"container-title":["Physiology &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938421002158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938421002158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:34:29Z","timestamp":1778636069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938421002158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":43,"alternative-id":["S0031938421002158"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2021.113525","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic agomelatine treatment alleviates icvA\u03b2-induced anxiety and depressive-like behavior through affecting A\u03b2 metabolism in the hippocampus in a rat model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2021.113525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113525"}}